Siltuximab

Tax included
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research.
MedChemExpress 
HY-P9956

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
Application
Cancer-programmed cell death
CAS
541502-14-1